Bluebird bio Inc : BLUE

All BLUE Articles

28 Articles

Chris Lange | Mar 10, 2021 at 12:41 PM EST

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including DraftKings, H&R…

Lee Jackson | Feb 17, 2021 at 8:58 AM EST

Top Analyst Upgrades and Downgrades: Agilent, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh, Palantir and More

Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh and Palantir Technologies.

Jon C. Ogg | Oct 20, 2020 at 8:57 AM EDT

Top Analyst Upgrades and Downgrades: AEP, Apache, AT&T, Bluebird, Fortinet, Intel, IBM, Kinder Morgan, New Residential, Snap, Verizon and More

Tuesday's top analyst upgrades and downgrades included American Electric Power, Apache, AT&T, ConocoPhillips, Bluebird Bio, Fortinet, Intel, IBM, Kinder Morgan,…

Chris Lange | Jun 2, 2020 at 8:26 AM EDT

Canaccord Genuity’s Key Takeaways From ASCO

Brokerage firm Canaccord Genuity issued some key takeaways on a few different companies at ASCO. 24/7 Wall St. has also…

Chris Lange | May 15, 2020 at 11:15 AM EDT

What Wedbush Sees Coming in ASCO’s 2020 Annual Meeting

Wedbush took a closer look at some of the companies in its coverage universe that are set to present at…

Jon C. Ogg | May 13, 2020 at 9:08 AM EDT

Top Analyst Upgrades and Downgrades: Bluebird Bio, Ciena, CommVault, Dollar General, JD.com, Kroger, Nucor, Target, Walmart and More

Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Ciena, CommVault Systems, Dollar General, JD.com, Kroger, Nucor, Target and Walmart.

Jon C. Ogg | Feb 3, 2020 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta…

Jon C. Ogg | Dec 13, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle,…

Chris Lange | Dec 12, 2019 at 12:05 PM EST

Wedbush’s Top Picks After ASH Annual Meeting

The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this…

Jon C. Ogg | Nov 26, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Agilent, Ambarella, Barclays, Bluebird Bio, Chipotle, Honeywell, McDonald’s Nutanix, NVIDIA, PagSeguro and More

Stocks closed up on Monday and shares were indicated up marginally on Tuesday morning. Investors are starting to see upside…

Jon C. Ogg | Nov 19, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack…

Jon C. Ogg | Nov 4, 2019 at 12:15 PM EST

After a 50% Drop, One Analyst Sees Bluebird Bio With Almost 50% Upside

On a day that the Dow Jones industrials and S&P 500 just hit all-time highs, many companies are not exactly…

Jon C. Ogg | Oct 1, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

Tuesday's top analyst upgrades, downgrades and initiations included Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron Technology, PG&E, Snap and…

1 2

Bluebird bio Inc : BLUE

All BLUE Articles

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

Top Analyst Upgrades and Downgrades: Agilent, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh, Palantir and More

Top Analyst Upgrades and Downgrades: AEP, Apache, AT&T, Bluebird, Fortinet, Intel, IBM, Kinder Morgan, New Residential, Snap, Verizon and More

Canaccord Genuity’s Key Takeaways From ASCO

What Wedbush Sees Coming in ASCO’s 2020 Annual Meeting

Top Analyst Upgrades and Downgrades: Bluebird Bio, Ciena, CommVault, Dollar General, JD.com, Kroger, Nucor, Target, Walmart and More

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Wedbush’s Top Picks After ASH Annual Meeting

Top Analyst Upgrades and Downgrades: Agilent, Ambarella, Barclays, Bluebird Bio, Chipotle, Honeywell, McDonald’s Nutanix, NVIDIA, PagSeguro and More

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

After a 50% Drop, One Analyst Sees Bluebird Bio With Almost 50% Upside

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Bluebird bio Inc : BLUE

All BLUE Articles

DraftKings, H&R Block, Novartis and More Wednesday Afternoon Analyst Calls

Top Analyst Upgrades and Downgrades: Agilent, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh, Palantir and More

Top Analyst Upgrades and Downgrades: AEP, Apache, AT&T, Bluebird, Fortinet, Intel, IBM, Kinder Morgan, New Residential, Snap, Verizon and More

Canaccord Genuity’s Key Takeaways From ASCO

What Wedbush Sees Coming in ASCO’s 2020 Annual Meeting

Top Analyst Upgrades and Downgrades: Bluebird Bio, Ciena, CommVault, Dollar General, JD.com, Kroger, Nucor, Target, Walmart and More

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Wedbush’s Top Picks After ASH Annual Meeting

Top Analyst Upgrades and Downgrades: Agilent, Ambarella, Barclays, Bluebird Bio, Chipotle, Honeywell, McDonald’s Nutanix, NVIDIA, PagSeguro and More

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

After a 50% Drop, One Analyst Sees Bluebird Bio With Almost 50% Upside

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not